What is Novosound?
Novosound Health is a pioneering medical technology firm specializing in the development of innovative, cuffless, and calibration-free blood pressure monitoring solutions. At the core of its product portfolio is the senseBP device, a handheld instrument that utilizes patented ultrasound technology to deliver precise, comfortable, and non-invasive readings. Unlike traditional inflatable cuffs, Novosound's solution is designed for seamless integration into both home-based patient care and clinical hospital environments.
The company occupies a strategic position within the digital health landscape, bridging the gap between complex diagnostic hardware and user-friendly consumer health tools. By focusing on accessibility and clinical-grade accuracy, Novosound is effectively addressing the growing demand for reliable, daily health monitoring technologies that empower patients and reduce the burden on healthcare systems.
How much funding has Novosound raised?
Novosound has raised a total of $10.7M across 4 funding rounds:
Angel/Seed
$1.1M
Unspecified
$2.7M
Unspecified
$4.4M
Unspecified
$2.6M
Angel/Seed (2018): $1.1M, investors not publicly disclosed
Unspecified (2019): $2.7M led by The Foresight Williams Technology EIS Fund, Foresight Scottish Growth Fund, and European Regional Development Fund
Unspecified (2019): $4.4M supported by Kelvin Capital, Foresight Scottish Growth Fund, University of the West of Scotland, Par Equity, Gabriel Investments, The Foresight Williams Technology EIS Fund, and Scottish Investment Bank
Unspecified (2024): $2.6M featuring Kelvin Capital, University of the West of Scotland, and Par Equity
Key Investors in Novosound
Kelvin Capital
Kelvin Capital is a venture capital firm specializing in revenue-generating growth companies, providing both financial backing and operational development support to high-potential businesses.
Par Equity
Par Equity is an Edinburgh-based venture capital firm focused on high-growth technology companies, with a specific interest in deep tech and healthcare innovation from Seed to Series A stages.
Scottish Investment Bank
The Scottish Investment Bank acts as the investment arm of Scotland's national economic development agency, supporting the growth of innovative companies through strategic capital and regional economic development initiatives.
What's next for Novosound?
With the recent capital infusion, Novosound is expected to scale its manufacturing capabilities and expand its footprint in international health markets. The strategic focus will likely shift toward deepening clinical validation and securing regulatory milestones necessary for widespread adoption of the senseBP platform. As the company transitions from development to broader market penetration, the continued support from its syndicate of venture capital and institutional partners will be instrumental in navigating the competitive landscape of medical device innovation.
Future growth initiatives will likely prioritize the integration of Novosound's ultrasound sensors into broader health-tech ecosystems, potentially unlocking new revenue streams through data-driven health insights and strategic partnerships with global healthcare providers.
